Bibliografia
1. NHS. Why Vaccination Is Important and the Safest Way to Protect Yourself. Available online: https://www.nhs.uk/conditions/
vaccinations/why-vaccination-is-important-and-the-safest-way-to-protect-yourself/ (accessed on 12 November 2023).
2. Stone, A.E.; Brummet, G.O.; Carozza, E.M.; Kass, P.H.; Petersen, E.P.; Sykes, J.; Westman, M.E. 2020 AAHA/AAFP Feline Vaccination Guidelines. J. Feline Med. Surg. 2020, 22, 813–830.
3. Richards, J.R.; Elston, T.H.; Ford, R.B.; Gaskell, R.M.; Hartmann, K.; Hurley, K.F.; Lappin, M.R.; Levy, J.K.; Rodan, I.; Scherk, M.; et al. The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel Report. J. Am. Vet. Med. Assoc. 2006, 229, 1405–1441.
4. Hosie, M.J.; Addie, D.D.; Boucraut-Baralon, C.; Egberink, H.; Frymus, T.; Gruffydd-Jones, T.; Hartmann, K.; Horzinek, M.C.; Lloret, A.; Lutz, H.; et al. Matrix Vaccination Guidelines. J. Feline Med. Surg. 2015, 17, 583–587.
5. Advisory Board on Cat Diseases (ABCD). Vaccination Recommended for Cats According to Lifestyle. Available online: https://www.abcdcatsvets.org/wp-content/uploads/2020/03/Tool_Vaccine-recommendations_Feb2020.pdf (accessed on 5 January 2023).
6. Day, M.J.; Horzinek, M.C.; Schultz, R.D.; Squires, R.A. WSAVA Guidelines for the Vaccination of Dogs and Cats. J. Small Anim. Pract. 2016, 57, E1–E45.
7. Day, M.J.; Karkare, U.; Schultz, R.D.; Squires, R.; Tsujimoto, H. Recommendations on Vaccination for Asian Small Animal Practitioners: A Report of the WSAVA Vaccination Guidelines Group. J. Small Anim. Pract. 2015, 56, 77–95.
8. WSAVA. Recomendaciones Sobre Vacunación Para Los Profesionales Latinoamericanos de Pequeños Animales: Un Informe Del Grupo de Directrices de Vacunación de WSAVA. Clínica Vet. 2020, 148, 36–91.
9. Australian Veterinary Association (AVA). Vaccination of Dogs and Cats. Available online: https://www.ava.com.au/policyadvocacy/policies/companion-animals-health/vaccination-of-dogs-and-cats/ (accessed on 16 January 2023).
10. British Veterinary Association (BVA). Getting Your Pet Vaccinated. Available online: https://www.bva.co.uk/media/2649/client_leaflet_9_-_getting_your_pet_vaccinated.pdf (accessed on 4 January 2023).
11. Vallée, B. Canadian Veterinary Medical Association Adopts a New Position Statement on Vaccination Protocols for Dogs and Cats. Can. Vet. J. 2008, 49, 362–365, quiz 365.
12. Joint American Veterinary Medical Association (AVMA)-Federation of Veterinarians of Europe (FVE)-Canadian Veterinary Medical Association (CVMA) Statement on the Benefits of Animal Vaccination Programs in Advancing Animal and Human Health. Available online: https://fve.org/cms/wp-content/uploads/AVMA-CVMA-FVE_vacconation_joint-paper.docx.pdf (accessed on 18 February 2023).
13. Sykes, J.; Parrish, C. Feline Panleukopenia Virus Infection and Other Feline Viral Enteritides. In Greene’s Infectious Diseases of the Dog and Cat; Sykes, J.E., Ed.; Elsevier: Amsterdam, The Netherlands, 2023; pp. 352–359.
14. Carrai, M.; Decaro, N.; Van Brussel, K.; Dall’Ara, P.; Desario, C.; Fracasso, M.; Šlapeta, J.; Colombo, E.; Bo, S.; Beatty, J.A.; et al. Canine Parvovirus Is Shed Infrequently by Cats without Diarrhoea in Multi-Cat Environments. Vet. Microbiol. 2021, 261, 109204. [CrossRef]
15. Decaro, N.; Buonavoglia, D.; Desario, C.; Amorisco, F.; Colaianni, M.L.; Parisi, A.; Terio, V.; Elia, G.; Lucente, M.S.; Cavalli, A.; et al. Characterisation of Canine Parvovirus Strains Isolated from Cats with Feline Panleukopenia. Res. Vet. Sci. 2010, 89, 275–278. [CrossRef]
16. Stuetzer, B.; Hartmann, K. Feline Parvovirus Infection and Associated Diseases. Vet. J. 2014, 201, 150–155. [CrossRef]
17. Truyen, U.; Parrish, C.R. Feline Panleukopenia Virus: Its Interesting Evolution and Current Problems in Immunoprophylaxis against a Serious Pathogen. Vet. Microbiol. 2013, 165, 29–32. [CrossRef] [PubMed]
18. Leisewitz, A. Canine and Feline Parvovirus Infection. In Textbook of Veterinary Internal Medicine; Ettinger, S., Feldman, E., Côté, E., Eds.; Elsevier: St. Louis, MI, USA, 2016; pp. 991–996.
19. Advisory Board on Cat Diseases (ABCD). Guideline for Feline Panleukopenia. Available online: https://www.abcdcatsvets.org/
guideline-for-feline-panleukopenia/ (accessed on 18 August 2023).
20. Maes, R. Felid Herpesvirus Type 1 Infection in Cats: A Natural Host Model for Alphaherpesvirus Pathogenesis. ISRN Vet. Sci. 2012, 2012, 495830.
21. Afonso, M.M.; Gaskell, R.M.; Radford, A. Feline Upper Respiratory Infections. In Textbook of Veterinary Internal Medicine; Ettinger, S., Feldman, E., Côté, E., Eds.; Elsevier: St Louis, MI, USA, 2016; pp. 1013–1015.
22. Advisory Board on Cat Diseases (ABCD). Guideline for Feline Herpesvirus Infection. Available online: https://www.abcdcatsvets.
org/guideline-for-feline-herpesvirus-infection/ (accessed on 18 August 2023).
23. Chan, I.; Dowsey, A.; Lait, P.; Tasker, S.; Blackwell, E.; Helps, C.R.; Barker, E.N. Prevalence and Risk Factors for Common Respiratory Pathogens within a Cohort of Pet Cats in the UK. J. Small Anim. Pract. 2023, 64, 552–560.
24. Sykes, J.; Lappin, M.; Thomasy, S.; Beatty, J. Feline Herpesvirus Infections. In Greene’s Infectious Diseases of the Dog and Cat; Sykes,
J., Ed.; Elsevier: St. Louis, MI, USA, 2023; pp. 301–309.
25. Advisory Board on Cat Diseses (ABCD). Guideline for Feline Calicivirus Infection. Available online: https://www.abcdcatsvets.
org/guideline-for-feline-calicivirus-infection/ (accessed on 18 August 2023).
26. Radford, A.; Afonso, M.; Sykes, J. Feline Calicivirus Infections. In Greene’s Infectious Diseases of the Dog and Cat; Sykes, J., Ed.; Elsevier: St. Louis, MI, USA, 2023; pp. 443–454.
27. Afonso, M.M.; Pinchbeck, G.L.; Smith, S.L.; Daly, J.M.; Gaskell, R.M.; Dawson, S.; Radford, A.D. A Multi-National European Cross-Sectional Study of Feline Calicivirus Epidemiology, Diversity and Vaccine Cross-Reactivity. Vaccine 2017, 35, 2753–2760.
28. Caringella, F.; Elia, G.; Decaro, N.; Martella, V.; Lanave, G.; Varello, K.; Catella, C.; Diakoudi, G.; Carelli, G.; Colaianni, M.L.; et al. Feline Calicivirus Infection in Cats with Virulent Systemic Disease, Italy. Res. Vet. Sci. 2019, 124, 46–51.
29. Dall’Ara, P. Vaccini e Vaccinazioni Degli Animali Da Compagnia, 1st ed.; Dall’Ara, P., Ed.; EDRA: Milano, Italy, 2020.
30. Little, S.; Levy, J.; Hartmann, K.; Hofmann-Lehmann, R.; Hosie, M.; Olah, G.; Denis, K.S. 2020 AAFP Feline Retrovirus Testing and Management Guidelines. J. Feline Med. Surg. 2020, 22, 5–30.
31. Jas, D.; Frances-Duvert, V.; Vernes, D.; Guigal, P.-M.; Poulet, H. Three-Year Duration of Immunity for Feline Herpesvirus and Calicivirus Evaluated in a Controlled Vaccination-Challenge Laboratory Trial. Vet. Microbiol. 2015, 177, 123–131.
32. Möstl, K. Duration of Vaccine-Induced Immunity. EJCAP 2016, 26, 4–8.
33. Mitchell, S.; Zwijnenberg, R.; Huang, J.; Hodge, A.; Day, M. Duration of Serological Response to Canine Parvovirus-Type 2, Canine Distemper Virus, Canine Adenovirus Type 1 and Canine Parainfluenza Virus in Client-Owned Dogs in Australia. Aust. Vet. J. 2012, 90, 468–473.
34. Ellis, J.; Marziani, E.; Aziz, C.; Brown, C.M.; Cohn, L.A.; Lea, C.; Moore, G.E.; Taneja, N. 2022 AAHA Canine Vaccination
Guidelines. J. Am. Anim. Hosp. Assoc. 2022, 58, 213–230.
35. Mouzin, D.E.; Lorenzen, M.J.; Haworth, J.D.; King, V.L. Duration of Serologic Response to Three Viral Antigens in Cats. JAVMA
2004, 224, 61–66.
36. Chastant-Maillard, S.; Aggouni, C.; Albaret, A.; Fournier, A.; Mila, H. Canine and Feline Colostrum. Reprod. Domest. Anim. 2017, 52, 148–152.
37. DiGangi, B.A.; Levy, J.K.; Griffin, B.; Reese, M.J.; Dingman, P.A.; Tucker, S.J.; Dubovi, E.J. Effects of Maternally-Derived Antibodies on Serologic Responses to Vaccination in Kittens. J. Feline Med. Surg. 2012, 14, 118–123.
38. Roth, J.A.; Spickler, A.R. Duration of Immunity Induced by Companion Animal Vaccines. Anim. Health Res. Rev. 2010, 11, 165–190.
39. Rashid, A.; Rasheed, K.; Akhtar, M. Factors Influencing Vaccine Efficacy—A General Review. J. Anim. Plant Sci. 2009, 19, 22–25.
40. Egberink, H.; Frymus, T.; Hartmann, K.; Möstl, K.; Addie, D.D.; Belák, S.; Boucraut-Baralon, C.; Hofmann-Lehmann, R.; Lloret, A.; Marsilio, F.; et al. Vaccination and Antibody Testing in Cats. Viruses 2022, 14, 1602.
41. Egberink, H.; Hartmann, K. ABCD Guideline for Vaccination and Antibody Titre Testing. Available online: https://www.abcdcatsvets.org/guideline-for-vaccination-and-antibody-titre-testing/ (accessed on 15 August 2023).
42. Egberink, H. The Role of Antibody Titer Testing in Vaccination Policy of Dog and Cat. Utrecht Univ. J. 2019, 14, 17–21.
43. Quimby, J.; Gowland, S.; Carney, H.C.; DePorter, T.; Plummer, P.;Westropp, J. 2021 AAHA/AAFP Feline Life Stage Guidelines.
J. Feline Med. Surg. 2021, 23, 211–233.
44. Biogal Galed Labs ACS Ltd. VacciCheck®Titer Testing. Available online: https://www.biogal.com/products/vaccicheck/ (accessed on 4 February 2023).
45. Day, M.J. Small Animal Vaccination: A Practical Guide for Vets in the UK. InPractice 2017, 39, 110–118.
46. Day, M. What We Need to Know about Vaccination and Titre Testing. In Proceedings of the British Small Animal Veterinary Association Congress, Birmingham, UK, 11–15 April 2012; pp. 1–7.
47. Coman, B.; Jones, E.; Westbury, H. Protozoan and Viral Infections of Feral Cats. Aust. Vet. J. 1981, 57, 319–323.
48. Yagami, K.; Furukawa, T.; Fukui, M. Serologic and Virologic Surveys on Feline Herpesvirus and Feline Calicivirus Infections in Cats for Experimental Use. Exp. Anim. 1985, 34, 241–248.
49. Yamaguchi, N.; MacDonald, D.; Passanisi, W.; Harbour, D.; Hopper, C. Parasite Prevalence in Free-Ranging Farm Cats, Felis Silvestris Catus. Epidemiol. Infect. 1996, 116, 217–223.
50. Miyazawa, T.; Ikeda, Y.; Nakamura, K.; Naito, R.; Mochizuki, M.; Tohya, Y.; Vu, D.; Mikami, T.; Takahashi, E. Isolation of Feline Parvovirus from Peripheral Blood Mononuclear Cells of Cats in Northern Vietnam. Microbiol. Immunol. 1999, 43, 609–612.
51. Nakamura, K.; Ikeda, Y.; Miyazawa, T.; Nguyen, N.; Duong, D.; Le, K.; Vo, S.; Phan, L.; Mikami, T.; Takahashi, E. Comparison of Prevalence of Feline Herpesvirus Type 1, Calicivirus and Parvovirus Infections in Domestic and Leopard Cats in Vietnam. J. Vet. Med. Sci. 1999, 61, 1313–1315.
52. Lappin, M.R.; Andrews, J.; Simpson, D.; Jensen,W.A. Use of Serologic Tests to Predict Resistance to Feline Herpesvirus 1, Feline Calicivirus, and Feline Parvovirus Infection in Cats. JAVMA 2002, 219, 38–42.
53. Ostrowski, S.; Van Vuuren, M.; Lenain, D.; Durand, A. A Serologic Survey of Wild Felids from Central West Saudi Arabia. J. Wildl. Dis. 2003, 39, 696–701.
54. Fischer, S.M.; Quest, C.M.; Dubovi, E.J.; Davis, R.D.; Tucker, S.J.; Friary, J.A.; Crawford, P.C.; Ricke, T.A.; Levy, J.K. Response of
Feral Cats to Vaccination at the Time of Neutering. JAVMA 2007, 230, 52–58.
55. Levy, J.K.; Crawford, P.C.; Lappin, M.R.; Dubovi, E.J.; Levy, M.G.; Alleman, R.; Tucker, S.J.; Clifford, E.L. Infectious Diseases of Dogs and Cats on Isabela Island, Galapagos. J. Vet. Intern. Med. 2008, 22, 60–65.
56. Blanco, K.; Prendas, J.; Cortes, R.; Jimenez, C.; Dolz, G. Seroprevalence of Viral Infections in Domestic Cats in Costa Rica. J. Vet. Medial Sci. 2009, 71, 661–663.
57. Hellard, E.; Fouchet, D.; Santin-Janin, H.; Tarin, B.; Badol, V.; Coupier, C.; Leblanc, G.; Poulet, H.; Pontier, D. When Cats’ Ways of Life Interact with Their Viruses: A Study in 15 Natural Populations of Owned and Unowned Cats (Felis Silvestris Catus). Prev. Vet. Med. 2011, 101, 250–264.
58. DiGangi, B.A.; Gray, L.K.; Levy, J.K.; Dubovi, E.J.; Tucker, S.J. Detection of Protective Antibody Titers against Feline Panleukopenia Virus, Feline Herpesvirus-1, and Feline Calicivirus in Shelter Cats Using a Point-of-Care ELISA. J. Feline Med. Surg. 2011, 13, 912–918.
59. DiGangi, B.A.; Levy, J.K.; Griffin, B.; McGorray, S.P.; Dubovi, E.J.; Dingman, P.A.; Tucker, S.J. Prevalence of Serum Antibody Titers against Feline Panleukopenia Virus, Feline Herpesvirus 1, and Feline Calicivirus in Cats Entering a Florida Animal Shelter. JAVMA 2012, 241, 1320–1325.
60. Mende, K.; Stuetzer, B.; Truyen, U.; Hartmann, K. Evaluation of an In-House Dot Enzyme-Linked Immunosorbent Assay to Detect Antibodies against Feline Panleukopenia Virus. J. Feline Med. Surg. 2014, 16, 805–811.
61. Mende, K.; Stuetzer, B.; Sauter-Louis, C.; Homeier, T.; Truyen, U.; Hartmann, K. Prevalence of Antibodies against Feline Panleukopenia Virus in Client-Owned Cats in Southern Germany. Vet. J. 2014, 199, 419–423.
62. Bergmann, M.; Schwertler, S.; Reese, S.; Speck, S.; Truyen, U.; Hartmann, K. Antibody Response to Feline Panleukopenia Virus Vaccination in Healthy Adult Cats. J. Feline Med. Surg. 2018, 20, 1087–1093.
63. Bergmann, M.; Speck, S.; Rieger, A.; Truyen, U.; Hartmann, K. Antibody Response to Feline Calicivirus Vaccination in Healthy Adult Cats. Viruses 2019, 11, 702.
64. Dall’Ara, P.; Labriola, C.; Sala, E.; Spada, E.; Magistrelli, S.; Lauzi, S. Prevalence of Serum Antibody Titres against Feline Panleukopenia, Herpesvirus and Calicivirus Infections in Stray Cats of Milan, Italy. Prev. Vet. Med. 2019, 167, 32–38.
65. Bergmann, M.; Speck, S.; Rieger, A.; Truyen, U.; Hartmann, K. Antibody Response to Feline Herpesvirus-1 Vaccination in Healthy Adult Cats. J. Feline Med. Surg. 2020, 22, 329–338.
66. Flatt Osborn, J. How Many Cats Are in theWorld? A Statistical Overview. Available online: https://worldanimalfoundation.org/ cats/how-many-cats-are-in-the-world/# (accessed on 21 August 2023).
67. Dall’Ara, P.; Lauzi, S.; Zambarbieri, J.; Servida, F.; Barbieri, L.; Rosenthal, R.; Turin, L.; Scarparo, E.; Filipe, J. Prevalence of Serum Antibody Titers against Core Vaccine Antigens in Italian Dogs. Life 2023, 13, 587.
68. Schultz, R.D. Duration of Immunity for Canine and Feline Vaccines: A Review. Vet. Microbiol. 2006, 117, 75–79.
69. Schultz, R.D.; Thiel, B.; Mukhtar, E.; Sharp, P.; Larson, L.J. Age and Long-Term Protective Immunity in Dogs and Cats. J. Comp. Pathol. 2010, 142, S102–S108.
70. Hofmann-Lehmann, R.; Hosie, M.J.; Hartmann, K.; Egberink, H.; Truyen, U.; Tasker, S.; Belák, S.; Boucraut-Baralon, C.; Frymus, T.; Lloret, A.; et al. Calicivirus Infection in Cats. Viruses 2022, 14, 937.
71. Radford, A.D.; Sommerville, L.; Ryvar, R.; Cox, M.B.; Johnson, D.R.; Dawson, S.; Gaskell, R.M. Endemic Infection of a Cat Colony with a Feline Calicivirus Closely Related to an
72. Barrs, V.R. Feline Panleukopenia: A Re-emergent Disease. Vet. Clin. N. Am. Small Anim. Pract. 2019, 49, 651–670.
73. Truyen, U.; Addie, D.; Belák, S.; Boucraut-Baralon, C.; Egberink, H.; Frymus, T.; Gruffydd-Jones, T.; Hartmann, K.; Hosie, M.J.; Lloret, A.; et al. Feline Panleukopenia: ABCD Guidelines on Prevention and Management. J. Feline Med. Surg. 2009, 11, 538–546.
74. Clegg, S.R.; Coyne, K.P.; Dawson, S.; Spibey, N.; Gaskell, R.M.; Radford, A.D. Canine Parvovirus in Asymptomatic Feline Carriers. Vet. Microbiol. 2012, 157, 78–85.
75. Clegg, S.R.; Coyne, K.P.; Parker, J.; Dawson, S.; Godsall, S.A.; Pinchbeck, G.; Cripps, P.J.; Gaskell, R.M.; Radford, A.D. Molecular
Epidemiology and Phylogeny Reveal Complex Spatial Dynamics in Areas Where Canine Parvovirus Is Endemic. J. Virol. 2011, 85, 7892–7899.
76. Nakamura, K.; Sakamoto, M.; Ikeda, Y.; Sato, E.; Kawakami, K.; Miyazawa, T.; Tohya, Y.; Takahashi, E.; Mikami, T.; Mochizuki, M. Pathogenic Potential of Canine Parvovirus Types 2a and 2c in Domestic Cats. Clin. Diagn. Lab. Immunol. 2001, 8, 663–668.
77. Munks, M.W.; Montoya, A.M.; Pywell, C.M.; Talmage, G.; Forssen, A.; Campbell, T.L.; Dodge, D.D.; Kappler, J.W.; Marrack, P. The Domestic Cat Antibody Response to Feline Herpesvirus-1 Increases with Age. Vet. Immunol. Immunopathol. 2017, 188, 65–70.
78. Dall’Ara, P. Immune System and Ageing in the Dog: Possible Consequences and Control Strategies. Vet. Res. Commun. 2003, 27, 535–542.
79. Hartmann, K.; Möstl, K.; Lloret, A.; Thiry, E.; Addie, D.D.; Belák, S.; Boucraut-Baralon, C.; Egberink, H.; Frymus, T.; Hofmann- Lehmann, R.; et al. Vaccination of Immunocompromised Cats. Viruses 2022, 14, 923.
80. Agarwal, S.K.; Irshad, M.; Dash, S.C. Comparison of Two Schedules of Hepatitis B Vaccination in Patients with Mild, Moderate and Severe Renal Failure. J. Assoc. Physicians India 1999, 47, 183–185.
81. DaRoza, G.; Loewen, A.; Djurdjev, O.; Love, J.; Kempston, C.; Burnett, S.; Kiaii, M.; Taylor, P.A.; Levin, A. Stage of Chronic Kidney Disease Predicts Seroconversion after Hepatitis B Immunization: Earlier Is Better. Am. J. Kidney Dis. 2003, 42, 1184–1192.
82. Lombardi, M.; Pizzarelli, F.; Righi, M.; Cerrai, T.; Dattolo, P.; Nigrelli, S.; Michelassi, S.; Sisca, S.; Alecci, A.; Di Geronimo, P.; et al. Hepatitis B Vaccination in Dialysis Patients and Nutritional Status. Nephron 1992, 61, 266–268.
83. Finch, N.C.; Syme, H.M.; Elliott, J. Risk Factors for Development of Chronic Kidney Disease in Cats. J. Vet. Intern. Med. 2016, 30, 602–610.
84. Beck, C.R.; McKenzie, B.C.; Hashim, A.B.; Harris, R.C.; Zanuzdana, A.; Agboado, G.; Orton, E.; Béchard-Evans, L.; Morgan, G.; Stevenson, C.; et al. Influenza Vaccination for Immunocompromised Patients: Summary of a Systematic Review and Meta-analysis. Influenza Other Respir. Viruses 2013, 7, 72–75.
85. Dall’Ara, P.; Filipe, J.; Pilastro, C.; Turin, L.; Lauzi, S.; Gariboldi, E.M.; Stefanello, D. Can Chemotherapy Negatively Affect the Specific Antibody Response toward Core Vaccines in Canine Cancer Patients? Vet. Sci. 2023, 10, 303.
86. Scott, F.; Geissinger, C. Long-Term Immunity in Cats Vaccinated with an Inactivated Trivalent Vaccine. Am. J. Vet. Res. 1999, 6, 652–658.
87. Dall’Ara, P.; Lauzi, S.; Filipe, J.; Caseri, R.; Beccaglia, M.; Desario, C.; Cavalli, A.; Aiudi, G.G.; Buonavoglia, C.; Decaro, N. Discrepancy Between In-Clinic and Haemagglutination-Inhibition Tests in Detecting Maternally-Derived Antibodies Against Canine Parvovirus in Puppies. Front. Vet. Sci. 2021, 8, 630809.
88. Meazzi, S.; Filipe, J.; Fiore, A.; Di Bella, S.; Mira, F.; Dall’Ara, P. Agreement between In-Clinics and Virus Neutralization Tests in Detecting Antibodies against Canine Distemper Virus (CDV). Viruses 2022, 14, 517.
89. Dall’Ara, P.; Lauzi, S.; Turin, L.; Castaldelli, G.; Servida, F.; Filipe, J. Effect of Aging on the Immune Response to Core Vaccines in Senior and Geriatric Dogs. Vet. Sci. 2023, 10, 412.
90. Dall’Ara, P.; Vitali, C.; Lasagna, C. Inaffidabilità Di Un Test Rapido per La Valutazione Della Protezione Anticorpale Verso i Vaccini Core Del Cane e Del Gatto. Veterinaria 2022, 36, 129–140.
91. Reese, M.; Patterson, E.; Tucker, S.; Dubovi, E.; Davis, R.; Crawford, P.; Levy, J. The Effect of Anesthesia and Surgery on Serological Responses to Vaccination in Kittens. JAVMA 2008, 233, 116–121.
92. Lappin, M.R. Feline Panleukopenia Virus, Feline Herpesvirus-1 and Feline Calicivirus Antibody Responses in Seronegative Specific Pathogen-Free Kittens after Parenteral Administration of an Inactivated FVRCP Vaccine or a Modified Live FVRCP Vaccine. J. Feline Med. Surg. 2012, 14, 161–164.
93. Dawson, S.;Willoughby, K.; Gaskell, R.;Wood, G.; Chalmers,W. A Field Trial to Assess the Effect of Vaccination against Feline Herpesvirus, Feline Calicivirus and Feline Panleucopenia Virus in 6-Week-Old Kittens. J. Feline Med. Surg. 2001, 3, 17–22.
94. Dodds, J. Vaccination and Antibody Tests: 2018 Update. Available online: https://www.vaccicheck.nl/sites/default/files/documents/serology_testing_clinical_review_dr_dodds_march_2018.pdf (accessed on 8 January 2023).
95. Tizard, I.; Ni, Y. Use of Serologic Testing to Assess Immune Status of Companion Animals. J. Am. Vet. Med. Assoc. 1998, 213, 54–60.
96. Tham, K.; Studdert, M.J. Antibody and Cell-Mediated Immune Responses to Feline Calicivirus Following Inactivated Vaccine and Challenge. Zentralbl Vet. B 1987, 34, 640–654.
97. Spiri, A.M.; Novacco, M.; Meli, M.L.; Stirn, M.; Riond, B.; Fogle, J.E.; Boretti, F.S.; Herbert, I.; Hosie, M.J.; Hofmann-Lehmann, R. Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study. Viruses 2021, 13, 1736.
98. Thiry, E.; Addie, D.; Belák, S.; Boucraut-Baralon, C.; Egberink, H.; Frymus, T.; Gruffydd-Jones, T.; Hartmann, K.; Hosie, M.J.; Lloret, A.; et al. Feline Herpesvirus Infection: ABCD Guidelines on Prevention and Management. J. Feline Med. Surg. 2009, 11, 547–555.
99. Mouzin, D.E.; Lorenzen, M.J.; Haworth, J.D.; King, V.L. Duration of Serologic Response to Five Viral Antigens in Dogs. JAVMA 2004, 224, 55–60.
100. Larson, L.J.; Schultz, R.D. Canine and Feline Vaccinations and Immunology. In Infectious Disease Management in Animal Shelters; Miller, L., Janeczko, S., Hurley, K.F., Eds.; JohnWiley & Sons, Inc.: Hoboken, NJ, USA, 2021.
101. Gore, T.; Lakshmanan, N.;Williams, J.; Jirjis, J.; Chester, S.; Duncan, K.; Coyne, M.; Lum, M.; Sterner, M. Three-Year Duration of Immunity in Cats Following Vaccination against Feline Rhinotracheitis Virus, Feline Calicivirus, and Feline Panleukopenia Virus. Vet. Ther. 2006, 7, 213–222.
102. Graf, R.; Guscetti, F.; Welle, M.; Meier, D.; Pospischil, A. Feline Injection Site Sarcomas: Data from Switzerland 2009–2014. J. Comp. Pathol. 2018, 163, 1–5.
103. Hartmann, K.; Day, M.J.; Thiry, E.; Lloret, A.; Frymus, T.; Addie, D.; Boucraut-Baralon, C.; Egberink, H.; Gruffydd-Jones, T.; Horzinek, M.C.; et al. Feline Injection-Site Sarcoma. J. Feline Med. Surg. 2015, 17, 606–613.
104. Hartmann, K.; Egberink, H.; Möstl, K.; Addie, D.D.; Belák, S.; Boucraut-Baralon, C.; Frymus, T.; Lloret, A.; Hofmann-Lehmann, R.; Marsilio, F.; et al. Feline Injection-Site Sarcoma and Other Adverse Reactions to Vaccination in Cats. Viruses 2023, 15, 1708.
105. Jas, D.; Frances-Duvert, V.; Brunet, S.; Oberli, F.; Guigal, P.-M.; Poulet, H. Evaluation of Safety and Immunogenicity of Feline Vaccines with Reduced Volume. Vaccine 2021, 39, 1051–1057.
106. McLain Madsen, L. Vaccine Transport, Storage, and Handling. Vet. Tech. 2011, 2011, E1–E4.
TORNA INDIETROPatologia comparata del tumore alla prostata del cane e dell'uomo
Sebbene relativamente raro nei cani, il cancro alla prostata (PCa) è il tumore non cutaneo più comune negli uomini. Le ghiandole prostatiche umane e canine condividono molte caratteristiche funzionali, anatomiche e fisiologiche. A causa di queste somiglianze, il PCa canino è stato proposto come modello per il PCa negli uomini.
